BACKGROUND: The high sequence and structural homology among the hsp90 paralogs - Hsp90α, Hsp90β, Grp94, and Trap-1 - has made the development of paralog-specific inhibitors a challenging proposition. OBJECTIVE: This review surveys the state of developments in structural analysis, compound screening, and structure-based design that have been brought to bear on this problem. RESULTS: First generation compounds that selectively bind to Hsp90, Grp94, or Trap-1 have been identified. CONCLUSION: With the proof of principle firmly established, the prospects for further progress are bright.
No takes yet. Share an insight, caveat, or question.
D.T. Gewirth (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: